Matthew Warr - Publications

Affiliations: 
2013 University of California, San Francisco, San Francisco, CA 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Kang YA, Paik H, Zhang SY, Chen JJ, Olson OC, Mitchell CA, Collins A, Swann JW, Warr MR, Fan R, Passegué E. Secretory MPP3 reinforce myeloid differentiation trajectory and amplify myeloid cell production. The Journal of Experimental Medicine. 220. PMID 37115584 DOI: 10.1084/jem.20230088  0.743
2018 Gaillard C, Surianarayanan S, Bentley T, Warr MR, Fitch B, Geng H, Passegué E, de Thé H, Kogan SC. Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia. Blood Advances. 2: 2462-2466. PMID 30266821 DOI: 10.1182/bloodadvances.2018018929  0.565
2017 Ho TT, Warr MR, Adelman ER, Lansinger OM, Flach J, Verovskaya EV, Figueroa ME, Passegué E. Autophagy maintains the metabolism and function of young and old stem cells. Nature. PMID 28241143 DOI: 10.1038/Nature21388  0.693
2015 Ugarte F, Sousae R, Cinquin B, Martin EW, Krietsch J, Sanchez G, Inman M, Tsang H, Warr M, Passegué E, Larabell CA, Forsberg EC. Progressive Chromatin Condensation and H3K9 Methylation Regulate the Differentiation of Embryonic and Hematopoietic Stem Cells. Stem Cell Reports. 5: 728-740. PMID 26489895 DOI: 10.1016/J.Stemcr.2015.09.009  0.76
2015 Asshoff M, Warr M, Haschka D, Tymoszuk P, Petzer V, Demetz E, Maciejewski P, Seifert M, Nairz M, Posch W, Fowles P, Weiss G, Whitney A, Theurl I. The Jak1/Jak2 Inhibitor Momelotinib Inhibits Alk2, Decreases Hepcidin Production and Ameliorates Anemia of Chronic Disease (ACD) in Rodents Blood. 126: 538-538. DOI: 10.1182/Blood.V126.23.538.538  0.309
2013 Warr MR, Kohli L, Passegué E. Born to survive: autophagy in hematopoietic stem cell maintenance. Cell Cycle (Georgetown, Tex.). 12: 1979-80. PMID 23759583 DOI: 10.4161/Cc.25303  0.79
2013 Warr MR, Binnewies M, Flach J, Reynaud D, Garg T, Malhotra R, Debnath J, Passegué E. FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature. 494: 323-7. PMID 23389440 DOI: 10.1038/Nature11895  0.717
2013 Warr MR, Passegué E. Metabolic makeover for HSCs. Cell Stem Cell. 12: 1-3. PMID 23290130 DOI: 10.1016/J.Stem.2012.12.005  0.71
2011 Pietras EM, Warr MR, Passegué E. Cell cycle regulation in hematopoietic stem cells. The Journal of Cell Biology. 195: 709-20. PMID 22123859 DOI: 10.1084/Jem20813Oia34  0.796
2011 Garcia D, Warr MR, Martins CP, Brown Swigart L, Passegué E, Evan GI. Validation of MdmX as a therapeutic target for reactivating p53 in tumors. Genes & Development. 25: 1746-57. PMID 21852537 DOI: 10.1101/Gad.16722111  0.53
2011 Warr MR, Pietras EM, Passegué E. Mechanisms controlling hematopoietic stem cell functions during normal hematopoiesis and hematological malignancies. Wiley Interdisciplinary Reviews. Systems Biology and Medicine. 3: 681-701. PMID 21412991 DOI: 10.1002/Wsbm.145  0.804
2010 Mohrin M, Bourke E, Alexander D, Warr MR, Barry-Holson K, Le Beau MM, Morrison CG, Passegué E. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell. 7: 174-85. PMID 20619762 DOI: 10.1016/J.Stem.2010.06.014  0.774
Show low-probability matches.